SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-21-015783
Filing Date
2021-05-04
Accepted
2021-05-04 17:28:20
Documents
80
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q brhc10023862_10q.htm 10-Q 658023
2 EXHIBIT 31.1 brhc10023862_ex31-1.htm EX-31.1 12327
3 EXHIBIT 31.2 brhc10023862_ex31-2.htm EX-31.2 12388
4 EXHIBIT 32.1 brhc10023862_ex32-1.htm EX-32.1 5329
5 EXHIBIT 32.2 brhc10023862_ex32-2.htm EX-32.2 5424
  Complete submission text file 0001140361-21-015783.txt   5031424

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aqst-20210331.xml EX-101.INS 685273
7 XBRL TAXONOMY EXTENSION SCHEMA aqst-20210331.xsd EX-101.SCH 61950
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aqst-20210331_cal.xml EX-101.CAL 57143
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aqst-20210331_def.xml EX-101.DEF 306747
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aqst-20210331_lab.xml EX-101.LAB 743612
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aqst-20210331_pre.xml EX-101.PRE 450185
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38599 | Film No.: 21890053
SIC: 2834 Pharmaceutical Preparations